JTC Team, LLC (NASDAQ:VLON) | Finanzwire

Basculer en Français

9473	Companies
185388	Keywords
117743	Articles
99274	Press releases

Home
Companies
JTC Team, LLC

BRIEF

published on 06/06/2024 at 16:35, 1 year 5 months ago

Outlook Therapeutics Receives European Authorization for LYTENAVA™

JTC Team Outlook Therapeutics LYTENAVA™ European Authorization Wet AMD
PRESS RELEASE

published on 06/06/2024 at 16:30, 1 year 5 months ago

Outlook Therapeutics(R) (NASDAQ:OTLK) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Outlook Therapeutics receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for wet AMD treatment. Watch the 'What This Means' video featuring CEO Russ Trenary

European Commission JTC Team Outlook Therapeutics LYTENAVA Wet AMD Treatment
BRIEF

published on 05/28/2024 at 19:05, 1 year 6 months ago

JTC Team to Host the Virtual Investor Pitch Conference on June 17-18, 2024

Investor Relations Webcast Live Q&A Virtual Investor Conference Corporate Communications
PRESS RELEASE

published on 05/28/2024 at 19:00, 1 year 6 months ago

JTC Team to Host the Virtual Investor Pitch Conference on June 17-18, 2024
JTC Team announces Virtual Investor Pitch Conference on June 17-18, 2024, featuring live video webcast presentations with Q&A. Participating company line-up to be revealed later

Investor Relations JTC Team Virtual Investor Pitch Conference Live Video Webcast Q&A
BRIEF

published on 05/23/2024 at 16:35, 1 year 6 months ago

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect

Investor Relations Corporate Communications GRI Bio Virtual Investor CEO Connect
PRESS RELEASE

published on 05/23/2024 at 16:30, 1 year 6 months ago

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect
JTC Team announces CEO Connect segment with GRI Bio's Marc Hertz, PhD, covering recent achievements and upcoming milestones. Virtual Investor platform offers more videos

GRI Bio Virtual Investor CEO Connect JTC Team Communication Strategies
BRIEF

published on 04/25/2024 at 15:50, 1 year 7 months ago

Moleculin Biotech Emphasizes Annamycin's Role in AML Treatment in JTC Virtual Investor Segment

Clinical Trials Investment Opportunity Moleculin Biotech Annamycin AML Treatment
PRESS RELEASE

published on 04/25/2024 at 15:45, 1 year 7 months ago

Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Moleculin CEO highlights Annamycin's differentiation in AML treatment landscape and investment opportunity. Positive interim data shared in 'What This Means' segment

Investment Opportunity Clinical Trial Moleculin Biotech Annamycin AML Treatment
PRESS RELEASE

published on 10/18/2023 at 16:00, 2 years 1 month ago

JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 48 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 53 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 23 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 18 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 23 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 18 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 22 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 22 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 23 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 23 minutes ago

Custodian Property Income REIT plc: Share Buyback

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 23 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 38 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 39 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE